Takeda Pharmaceutical Co Ltd Ratios

Ratios Mar2017 Mar2018 Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Profitability
Gross Margin 67.74%71.99%68.92%66.89%68.91%68.99%69.11%66.54%65.51%
EBT Margin 8.28%12.27%6.08%-1.85%11.45%8.48%9.31%1.24%3.82%
EBIT Margin 9.00%13.66%11.33%3.05%15.93%12.91%12.18%5.02%7.48%
EBITDA Margin 9.00%13.66%11.33%3.05%15.93%12.91%12.18%5.02%7.48%
Operating Margin 9.00%13.66%11.33%3.05%15.93%12.91%12.18%5.02%7.48%
Net Margin 6.64%10.56%6.45%1.34%11.76%6.45%7.87%3.38%2.36%
FCF Margin 13.88%19.24%14.10%23.38%34.44%31.95%25.39%17.43%21.98%
Efficiency
Inventory Average 5.11B7.64B7.05B7.36B7.45B7.85B8.19B
Equity Average 18.12B32.50B45.14B46.17B49.74B48.84B48.74B47.99B
Invested Capital 18.02B27.11B98.68B90.36B92.56B89.35B79.48B84.03B75.18B
Leverage & Solvency
Interest Coverage Ratio 6.707.572.850.612.052.772.890.971.63
Debt to Equity 0.501.111.080.940.760.690.670.65
Times Interest Earned 6.707.572.850.612.052.772.890.971.63
Dividends & Payouts
FCF Payout Ratio 0.600.420.480.370.260.250.270.390.30
Valuation
Enterprise Value -2.95B-3.39B49.55B41.50B47.43B36.98B47.00B40.31B44.48B
Market Capitalization 56.09B47.51B56.89B44.77B51.10B43.58B47.14B
Return Ratios
Return on Sales 0.07%0.11%0.06%0.01%0.12%0.06%0.08%0.03%0.02%
Return on Invested Capital 0.08%0.03%0.04%0.02%
Return on Equity 0.09%0.04%0.01%0.08%0.04%0.05%0.02%0.01%